These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 29696728)
1. Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD. Hartjes FJ; Vonk JM; Faiz A; Hiemstra PS; Lapperre TS; Kerstjens HAM; Postma DS; van den Berge M; Respirology; 2018 Nov; 23(11):1023-1031. PubMed ID: 29696728 [TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids, blood eosinophils, and FEV Whittaker HR; Müllerova H; Jarvis D; Barnes NC; Jones PW; Compton CH; Kiddle SJ; Quint JK Int J Chron Obstruct Pulmon Dis; 2019; 14():1063-1073. PubMed ID: 31213788 [No Abstract] [Full Text] [Related]
3. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts. Cheng SL; Lin CH Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344 [TBL] [Abstract][Full Text] [Related]
4. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER; Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301 [TBL] [Abstract][Full Text] [Related]
5. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up. Pignatti P; Visca D; Zappa M; Zampogna E; Saderi L; Sotgiu G; Centis R; Migliori GB; Spanevello A BMC Pulm Med; 2024 May; 24(1):247. PubMed ID: 38764008 [TBL] [Abstract][Full Text] [Related]
6. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging. De Backer J; Vos W; Vinchurkar S; Van Holsbeke C; Poli G; Claes R; Salgado R; De Backer W J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168 [TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. Vestbo J; Vogelmeier CF; Small M; Siddall J; Fogel R; Kostikas K Int J Chron Obstruct Pulmon Dis; 2019; 14():853-861. PubMed ID: 31114183 [No Abstract] [Full Text] [Related]
8. Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts. Saito Z; Yoshida M; Kojima A; Tamura K; Hasegawa T; Kuwano K Lung; 2020 Dec; 198(6):925-931. PubMed ID: 33068153 [TBL] [Abstract][Full Text] [Related]
9. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Kitaguchi Y; Komatsu Y; Fujimoto K; Hanaoka M; Kubo K Int J Chron Obstruct Pulmon Dis; 2012; 7():283-9. PubMed ID: 22589579 [TBL] [Abstract][Full Text] [Related]
10. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids. Kunz LI; Ten Hacken NH; Lapperre TS; Timens W; Kerstjens HA; van Schadewijk A; Vonk JM; Sont JK; Snoeck-Stroband JB; Postma DS; Sterk PJ; Hiemstra PS; Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28049170 [TBL] [Abstract][Full Text] [Related]
11. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD. Mathioudakis AG; Bikov A; Foden P; Lahousse L; Brusselle G; Singh D; Vestbo J Eur Respir J; 2020 May; 55(5):. PubMed ID: 32108044 [TBL] [Abstract][Full Text] [Related]
12. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Rutgers SR; Timens W; Kaufmann HF; van der Mark TW; Koëter GH; Postma DS Eur Respir J; 2000 Jan; 15(1):109-15. PubMed ID: 10678630 [TBL] [Abstract][Full Text] [Related]
13. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD. Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740 [TBL] [Abstract][Full Text] [Related]
14. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933 [TBL] [Abstract][Full Text] [Related]
15. Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil-to-lymphocyte ratio, and mortality outcomes in US adults. Hu HS; Wang Z; Jian LY; Zhao LM; Liu XD Front Immunol; 2023; 14():1230766. PubMed ID: 38035096 [TBL] [Abstract][Full Text] [Related]
16. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis. Cheng SL Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168 [TBL] [Abstract][Full Text] [Related]
17. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469 [TBL] [Abstract][Full Text] [Related]
18. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease. Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888 [TBL] [Abstract][Full Text] [Related]